Cost-effectiveness analysis of MRI, CE-CT and 18F-FDG PET/CT for detecting colorectal liver metastases eligible for hepatic resection

OBJECTIVES: Colorectal cancer (CRC) is a serious challenge for the health system. In 2022 CRC represented 8% of cancer diagnoses in the United States. 30% of patients already show metastases at the initial tumor staging. The majority of these metastases are sited in the liver. According to their ext...

Descripción completa

Detalles Bibliográficos
Autores principales: Schnitzer, Moritz L., von Münchhausen, Niklas, Biechele, Gloria, Runtemund, Jasmin, Grawe, Freba, Geyer, Thomas, Kaiser, Clemens G., Haag, Florian, Rübenthaler, Johannes, Froelich, Matthias F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405934/
https://www.ncbi.nlm.nih.gov/pubmed/37554160
http://dx.doi.org/10.3389/fonc.2023.1161738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405934/
https://www.ncbi.nlm.nih.gov/pubmed/37554160
http://dx.doi.org/10.3389/fonc.2023.1161738

Ejemplares similares